Docetaxel (Taxotere) and 5-fluorouracil as second- or third-line chemotherapy in women with metastatic breast cancer.
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2017
At a glance
- Drugs Docetaxel (Primary) ; Fluorouracil (Primary) ; Folinic acid
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Jul 2012 Actual initiation date changed from 1 May 2001 to 1 Jan 1997 as reported by ClinicalTrials.gov.
- 22 Sep 2009 Actual end date (Jul 2009) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.